In conversation — Biomarker-guided therapy and the future of oncology

About this Podcast

From a workflow perspective, early intervention correlates with better long-term outcomes, which has direct implications for daily practice. When protocols are compared, training and accreditation are decisive for reproducibility, although confirmatory data are still limited. Across multiple cohorts, variability between operators remains a key limitation, as discussed in the accompanying commentary. When protocols are compared, variability between operators remains a key limitation, which has direct implications for daily practice. Contrary to earlier assumptions, threshold harmonization is still an open question, which has direct implications for daily practice. Across multiple cohorts, standardized reporting improves comparability between centers, a finding echoed by several independent groups. In routine practice, digital tooling shortens time-to-decision considerably, and this trend is expected to continue. Across multiple cohorts, integrating quantitative measures reduces subjective bias, particularly in resource-constrained settings.